« Back to Glossary Index« Back to Glossary Index
On December 14, 2016, the DEA implemented new rules regarding CBD when it defined “marihuana extracts” to include any extract “containing one or more cannabinoids that has been derived from any plant of the genus Cannabis.” At the time, this appeared to move CBD and other non-psychoactive compounds into the Schedule 1 category that also includes “heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.”
